This topic contains a solution. Click here to go to the answer

Author Question: A patient has been taking isoniazid Nydrazid for 4 months for latent tuberculosis. The patient ... (Read 87 times)

stock

  • Hero Member
  • *****
  • Posts: 573
A patient has been taking isoniazid Nydrazid for 4 months for latent tuberculosis. The patient reports bilateral tingling and numbness of the hands and feet, as well as feeling clumsy. The nurse expects the provider to:
 
  a. discontinue the isoniazid.
  b. lower the isoniazid dose and add rifampin.
  c. order pyridoxine 100 mg per day.
  d. recheck the tuberculin skin test to see whether it worsens.

Question 2

A patient with gout who has increasingly frequent acute gouty attacks will begin receiving allopurinol Zyloprim and colchicine. The nurse will include which statement when teaching the patient about this drug regimen?
 
  a. Allopurinol helps reduce the gastrointes-tinal side effects of colchicine.
  b. Allopurinol reduces the likelihood of gouty episodes that usually occur with initial colchicine therapy.
  c. The colchicine is given to enhance the effects of the allopurinol.
  d. You will take both drugs initially and then stop taking the colchicine.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Liddy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

C
Patients sometimes develop peripheral neuropathy, characterized by paresthesias, clumsiness, and muscle aches. If these occur, they may be reversed by administering pyridoxine (vitamin B6). It is not necessary to discontinue the isoniazid. Lowering the isoniazid dose and adding rifampin is not indicated. Rechecking the TST is not indicated.

Answer to Question 2

D
Colchicine is used for prophylaxis when urate-lowering drugs, such as allopurinol, are initiated, because gouty episodes have a tendency to increase during this time. Patients start with both drugs, and ultimately the colchicine is withdrawn. Allopurinol does not affect the GI side effects caused by colchicine. Allopurinol may precipitate an acute gouty attack when treatment is begun; colchicine is given to prevent a gouty episode. Colchicine does not enhance the effects of allopu-rinol.




stock

  • Member
  • Posts: 573
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


sultana.d

  • Member
  • Posts: 320
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

For a complete list of videos, visit our video library